The central THαβ immunity associated cytokine: IL-10 has a strong anti-tumor ability toward established cancer models in vivo and toward cancer cells in vitro
This study demonstrates that IL-10 from the THβ immunity pathway effectively reduces tumor growth and improves survival in vivo and directly kills cancer cells in vitro, while IFN-γ has adverse effects.